top of page
Logo(Vivid).png

Platform

ECLS (EcML-CoPoP Liposome)

The ECLS platform strategically integrates EuBiologics’ proprietary EuIMT technology with POP Biotech’s SNAP technology. By combining advanced antigen display with targeted immune enhancement, ECLS maximizes both humoral and cellular immune responses to pioneer the next generation of high-efficacy vaccines.

ecls_edited.png

EuPOP

Combined Innovation

EuPOP is the result of fruitful collaborations between Eubiologics and POP Biotechnologies. By combining their expertise and technologies, EuPOP aims to deliver innovative solutions to various challenges in the biotech industry. Stay tuned for updates on our latest developments and breakthroughs.

eubiologics.png

[EcML, TLR4 Agonist]

EuIMT

ecml.avif

SNAP Technology

snap1.avif
snap2.avif
bottom of page